123 related articles for article (PubMed ID: 28235034)
1. NFATc1 phosphorylation by DYRK1A increases its protein stability.
Liu H; Wang K; Chen S; Sun Q; Zhang Y; Chen L; Sun X
PLoS One; 2017; 12(2):e0172985. PubMed ID: 28235034
[TBL] [Abstract][Full Text] [Related]
2. DYRK1A activates NFATC1 to increase glioblastoma migration.
Liu H; Sun Q; Chen S; Chen L; Jia W; Zhao J; Sun X
Cancer Med; 2021 Sep; 10(18):6416-6427. PubMed ID: 34309232
[TBL] [Abstract][Full Text] [Related]
3. The small molecule harmine regulates NFATc1 and Id2 expression in osteoclast progenitor cells.
Egusa H; Doi M; Saeki M; Fukuyasu S; Akashi Y; Yokota Y; Yatani H; Kamisaki Y
Bone; 2011 Aug; 49(2):264-74. PubMed ID: 21504804
[TBL] [Abstract][Full Text] [Related]
4. E3 Ligase SCFβTrCP-induced DYRK1A Protein Degradation Is Essential for Cell Cycle Progression in HEK293 Cells.
Liu Q; Tang Y; Chen L; Liu N; Lang F; Liu H; Wang P; Sun X
J Biol Chem; 2016 Dec; 291(51):26399-26409. PubMed ID: 27807027
[TBL] [Abstract][Full Text] [Related]
5. DYRK1A Controls HIV-1 Replication at a Transcriptional Level in an NFAT Dependent Manner.
Booiman T; Loukachov VV; van Dort KA; van 't Wout AB; Kootstra NA
PLoS One; 2015; 10(12):e0144229. PubMed ID: 26641855
[TBL] [Abstract][Full Text] [Related]
6. Dyrk1A phosphorylates parkin at Ser-131 and negatively regulates its ubiquitin E3 ligase activity.
Im E; Chung KC
J Neurochem; 2015 Aug; 134(4):756-68. PubMed ID: 25963095
[TBL] [Abstract][Full Text] [Related]
7. Negative feedback Inhibition of NFATc1 by DYRK1A regulates bone homeostasis.
Lee Y; Ha J; Kim HJ; Kim YS; Chang EJ; Song WJ; Kim HH
J Biol Chem; 2009 Nov; 284(48):33343-51. PubMed ID: 19801542
[TBL] [Abstract][Full Text] [Related]
8. Novel Scaffolds for Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase (DYRK1A) Inhibitors.
Czarna A; Wang J; Zelencova D; Liu Y; Deng X; Choi HG; Zhang T; Zhou W; Chang JW; Kildalsen H; Seternes OM; Gray NS; Engh RA; Rothweiler U
J Med Chem; 2018 Sep; 61(17):7560-7572. PubMed ID: 30095246
[TBL] [Abstract][Full Text] [Related]
9. p53 downregulates Down syndrome-associated DYRK1A through miR-1246.
Zhang Y; Liao JM; Zeng SX; Lu H
EMBO Rep; 2011 Jun; 12(8):811-7. PubMed ID: 21637297
[TBL] [Abstract][Full Text] [Related]
10. K63-linked ubiquitination of DYRK1A by TRAF2 alleviates Sprouty 2-mediated degradation of EGFR.
Zhang P; Zhang Z; Fu Y; Zhang Y; Washburn MP; Florens L; Wu M; Huang C; Hou Z; Mohan M
Cell Death Dis; 2021 Jun; 12(6):608. PubMed ID: 34117217
[TBL] [Abstract][Full Text] [Related]
11. Dual-specificity tyrosine phosphorylation-regulated kinase 1A does not require tyrosine phosphorylation for activity in vitro.
Adayev T; Chen-Hwang MC; Murakami N; Lee E; Bolton DC; Hwang YW
Biochemistry; 2007 Jun; 46(25):7614-24. PubMed ID: 17536841
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of dual specificity kinase activity of DYRK1A.
Walte A; Rüben K; Birner-Gruenberger R; Preisinger C; Bamberg-Lemper S; Hilz N; Bracher F; Becker W
FEBS J; 2013 Sep; 280(18):4495-511. PubMed ID: 23809146
[TBL] [Abstract][Full Text] [Related]
13. Validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome.
Granese B; Scala I; Spatuzza C; Valentino A; Coletta M; Vacca RA; De Luca P; Andria G
BMC Med Genomics; 2013 Jul; 6():24. PubMed ID: 23830204
[TBL] [Abstract][Full Text] [Related]
14. Dual-specificity tyrosine-phosphorylation regulated kinase 1A Gene Transcription is regulated by Myocyte Enhancer Factor 2D.
Wang P; Wang L; Chen L; Sun X
Sci Rep; 2017 Aug; 7(1):7240. PubMed ID: 28775333
[TBL] [Abstract][Full Text] [Related]
15. SIRT1 negatively regulates the protein stability of HIPK2.
Hwang J; Lee SY; Choi JR; Shin KS; Choi CY; Kang SJ
Biochem Biophys Res Commun; 2013 Nov; 441(4):799-804. PubMed ID: 24211575
[TBL] [Abstract][Full Text] [Related]
16. Lysine 313 of T-box is crucial for modulation of protein stability, DNA binding, and threonine phosphorylation of T-bet.
Jang EJ; Park HR; Hong JH; Hwang ES
J Immunol; 2013 Jun; 190(11):5764-70. PubMed ID: 23616576
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the stability and transcriptional activity of NFATc4 by ubiquitination.
Fan Y; Xie P; Zhang T; Zhang H; Gu D; She M; Li H
FEBS Lett; 2008 Dec; 582(29):4008-14. PubMed ID: 19026640
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo.
Grebe C; Klingebiel TM; Grau SP; Toischer K; Didié M; Jacobshagen C; Dullin C; Hasenfuss G; Seidler T
Cardiovasc Res; 2011 Jun; 90(3):521-8. PubMed ID: 21273244
[TBL] [Abstract][Full Text] [Related]
19. Dyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb/E2f-signalling.
Hille S; Dierck F; Kühl C; Sosna J; Adam-Klages S; Adam D; Lüllmann-Rauch R; Frey N; Kuhn C
Cardiovasc Res; 2016 Jun; 110(3):381-94. PubMed ID: 27056896
[TBL] [Abstract][Full Text] [Related]
20. DYRK1A stabilizes HPV16E7 oncoprotein through phosphorylation of the threonine 5 and threonine 7 residues.
Liang YJ; Chang HS; Wang CY; Yu WC
Int J Biochem Cell Biol; 2008; 40(11):2431-41. PubMed ID: 18468476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
